Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-03-054680
Filing Date
2003-09-26
Accepted
2003-09-26 15:43:12
Documents
8
Period of Report
2003-06-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT d10k.htm 10-K 783895
3 SUBSIDIARIES OF THE COMPANY dex211.htm EX-21.1 2242
4 CONSENT OF INDEPENDENT AUDITORS - ERNST & YOUNG LLP dex231.htm EX-23.1 1693
5 INDEPENDENT ACCOUNTANTS' CONSENT - KPMG LLP dex232.htm EX-23.2 2118
6 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 9609
7 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 9626
8 CERTIFICATION PURSUANT TO SECTION 906 dex321.htm EX-32.1 3678
9 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 dex322.htm EX-32.2 3798
  Complete submission text file 0001193125-03-054680.txt   819139
Mailing Address 300 AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address 300 AMERICAN RD MORRIS PLAINS NJ 07950 9736058200
IMMUNOMEDICS INC (Filer) CIK: 0000722830 (see all company filings)

EIN.: 611009366 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-12104 | Film No.: 03912527
SIC: 2835 In Vitro & In Vivo Diagnostic Substances